Practice Tips

A new KLAS case study highlights key outcomes of a Surescripts-led collaboration with three organizations.

Quetiapine tablets are an atypical antipsychotic indicated for the treatment of schizophrenia and bipolar disorder.

The partnership will provide funding for pharmacists to attend mental health trainings and webinars focused on self-care for pharmacists, their staff and patients.

Crexont extended-release capsules are used to treat Parkinson’s disease.

TPG, a global alternative asset management firm, will join the Surescripts ownership group as a majority investor.

Vaccines greatly impacted the trajectory of the pandemic, but it’s clear that the perceived value of vaccination during that time has rapidly declined.

The brand touts its new material as an eco-friendly alternative that offers flexibility and durability comparable to neoprene.

Ocrevus Zunovo with Halozyme's Enhanze drug delivery technology is used for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis.